Delivery Order #36C25226F0447

Delivery Order for Andembry Auto Injector from CSL Behring under FSS Contract

This contract award is a delivery order issued to CSL Behring L.L.C., a key player in the biopharmaceutical industry specializing in drugs and hematology products. The order covers the procurement of Andembry (Garadacimab-GXII) 200mg/1.2ml auto injectors, a specialized pharmaceutical product intended to meet specific medical needs. The contract falls under a broader Federal Supply Schedule (FSS) agreement previously awarded to CSL Behring, highlighting its role in supplying essential medications through a competitive, multi-year federal sourcing agreement. This particular delivery order underscores the ongoing relationship between CSL Behring and the government, delivering precise pharmaceutical products critical for healthcare provision. The work scope is defined by the supply and timely delivery of these auto injectors to the designated location in King of Prussia, Pennsylvania, ensuring continuity in healthcare services. The contract was awarded through the existing FSS vehicle, which was competitively procured, maintaining transparency and fair competition. The contract timeline is concise, reflecting a short-term delivery schedule within the specified period in September 2026. This award further strengthens the agency's capacity to provide vital medical products, demonstrating the significance of reliable vendors in supporting public health initiatives.

Description

ANDEMBRY (GARADACIMAB-GXII) 200MG/1.2ML AUTO INJECTOR

View original record